TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Igelösa Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
7,110
|
10,465
|
9,262 |
Financial expenses |
0
|
2
|
1 |
Earnings before taxes |
881
|
1,432
|
1,241 |
EBITDA |
455
|
1,297
|
-1,933 |
Total assets |
35,638
|
32,420
|
33,791 |
Current assets |
15,000
|
12,966
|
13,540 |
Current liabilities |
2,077
|
1,688
|
3,224 |
Equity capital |
33,403
|
30,584
|
30,414 |
- share capital |
1,013
|
946
|
975 |
Employees (average) |
9
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
93.7%
|
94.3%
|
90.0% |
Turnover per employee |
790
|
1,046
|
926 |
Profit as a percentage of turnover |
12.4%
|
13.7%
|
13.4% |
Return on assets (ROA) |
2.5%
|
4.4%
|
3.7% |
Current ratio |
722.2%
|
768.1%
|
420.0% |
Return on equity (ROE) |
2.6%
|
4.7%
|
4.1% |
Change turnover |
-4,097
|
1,481
|
-915 |
Change turnover % |
-37%
|
16%
|
-9% |
Chg. No. of employees |
-1
|
0
|
-3 |
Chg. No. of employees % |
-10%
|
0%
|
-23% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.